news
Novavax’s COVID-19 vaccine highly effective in preventing disease
New Phase III trial data suggests Novavax’s investigational COVID-19 vaccine, NVX-CoV2373, is 90 percent effective at preventing COVID-19 illness.
List view / Grid view
University of Maryland School of Medicine
article
The Editors’ views: European Pharmaceutical Review’s 2020 round-up
Junior Editors of European Pharmaceutical Review, Hannah Balfour and Victoria Rees, discuss some of the most noteworthy news and announcements from this year.
article
Biopharma Processing & Development In-Depth Focus 2019
Today’s biopharmaceutical developers need accurate and precise information at all stages of research and development in order to bring safe and effective therapies to patients. This in-depth focus features novel perspectives from industry experts that serve to illustrate which technologies and systems are benefitting this cause.
news
3-D-printed prosthetic implants could improve treatment for hearing loss
Using CT scans and 3-D printing researchers have created accurate, custom-designed prosthetic replacements for damaged parts of the middle ear...
